Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

10x Genomics, Inc. Director's Dealing 2024

Jul 19, 2024

31830_dirs_2024-07-19_6a78a3da-d32f-4485-ae9b-f8b231fdbab7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2024-07-10

Reporting Person: Teichmann Sarah A. (N/A)

More from 10x Genomics, Inc.

Regulatory Filings 2026
May 7
Proxy Solicitation & Information Statement 2026
Apr 24
Director's Dealing 2026
Mar 25
Major Shareholding Notification 2026
Mar 25
Director's Dealing 2026
Mar 4
Director's Dealing 2026
Mar 2
Director's Dealing 2026
Mar 2
Director's Dealing 2026
Mar 2
Director's Dealing 2026
Feb 27
Director's Dealing 2026
Feb 25
View all filings →